NHS launches pill to cut alcohol cravings

A pill that promises to reduce the desire to drink alcohol is now available on prescription from the NHS in England.


Nalmefene, a pill to stop alcohol cravings, was launched on the NHS today.

Nalmefene, a once-a-day pill that reduces the “buzz” of drinking to help control alcohol cravings, won the approval of health officials in England in July. Today, the £3 pill was officially launched with patients now able to request the drug from the NHS alongside counselling services to cut down their drinking.

Anyone who regularly drinks high amounts of alcohol, defined by the World Health Organisation as 7.5 units a day for men and 5 units a day for women, roughly at least half a bottle of wine or three pints a night, will be eligible for the drug.

The drug, also known as Selincro, can be take once a day and is designed to be taken whenever the patients feels the desire to have a drink.

Importantly, the drug is designed for those who are concerned about their drinking and want to cut down, not those with a severe alcohol problem.

Fictional examples provided by the drug’s manufacturer of who the drug is aimed at include Sue, 39, who “looks forward to a glass of wine after work when the kids go to bed but always finishes the bottle while cooking and eating with her husband, and opens a second bottle a few days each week”.

Lyndsey Dudley, a spokeswoman for the National Institute for Health and Care Excellence (NICE), said the drug would be suitable for people who “probably don’t even recognise themselves as an alcoholic”, with 35,000 people expected to benefit in the first year.

Professor Carole Longson, Nice’s health technology evaluation centre director, added: “Many people have a difficult relationship with alcohol even though they have a very stable lifestyle, maintain jobs and a social life and would not automatically assume they have a problem. But regularly drinking over the recommended daily amount of alcohol can seriously damage your health. Those who could be prescribed nalmefene have already taken the first big steps by visiting their doctor, engaging with support services and taking part in therapy programmes. We are pleased to be able to recommend the use of namelfene to support people further in their efforts to fight alcohol dependence.”

The drug is already in use in Scotland which became the first European country to prescribe it in October last year, while a separate consultation on whether it will be made available in Wales and Northern Ireland is yet to take place.

Leave a Reply

Your email address will not be published. Required fields are marked *

Please note that comments are subject to our posting guidelines in accordance with the Defamation Act 2013. Posts containing swear words, discrimination, offensive language and libellous or defamatory comments will not be approved.

We encourage debate in the comments section and always welcome feedback, but if you spot something you don't think is right, we ask that you leave an accurate email address so we can get back to you if we need to.

Subscribe to our newsletters

Supply Chain Assistant

Speciality Drinks
London NW10 7SF, UK

Supply Chain Co-ordinator

Speciality Drinks
London NW10 7SF, UK

On-Trade Regional Sales Manager

Anthony Byrne Fine Wines
West Midlands & Northants

Logistics Team Leader

Speciality Drinks
London, UK

Key Account Executive

Berkmann Wine Cellars
London, UK

Assistant Operations Manager

Speciality Drinks
London, UK

Technical Manager

North South Wines
West Drayton, UK

Key Account Manager

MMI Maldives


Eurowines Limited
Harrogate, UK

Business Manager - Impulse

Australian Vintage
Croydon, UK

Exclusive Masterclass: Chablis on Tour

London,United Kingdom
29th Apr 2019

Vinexpo Bordeaux

13th May 2019

London Wine Fair 2019

London,United Kingdom
20th May 2019
Click to view more

The Global Grenache Masters 2019

Deadline : 26th April 2019

The Tuscan Masters 2019

Deadline : 26th April 2019

Click to view more

The Global Riesling Masters 2018

View Results

Rioja Masters 2018

View Results

Click to view more